United States Formulation CDMO Services Market was valued at USD 12.6 Billion in 2022 and is projected to reach USD 20.2 Billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030.
The US Formulation CDMO Services Market is rapidly growing, driven by increasing demand for specialized services from pharmaceutical, biotechnology, and nutraceutical industries. Contract Development and Manufacturing Organizations (CDMOs) offer essential formulation services that support companies in the development of their drug products, making them a critical part of the pharmaceutical supply chain. These services typically include drug formulation, testing, production, and regulatory support, allowing companies to streamline their operations and reduce the complexities involved in bringing products to market.
One of the key factors driving the growth of the Formulation CDMO Services Market is the increasing need for customized drug formulations. Pharmaceutical companies are under pressure to develop personalized medicines that cater to individual patient needs, and CDMOs provide the expertise and flexibility to meet these challenges. Additionally, with rising demand for complex biologics and biosimilars, CDMOs are becoming more essential for their ability to handle intricate manufacturing processes.
Industries such as the pharmaceutical, biotechnology, and nutraceutical sectors require CDMO services to not only develop and manufacture drug formulations but also to ensure regulatory compliance and meet market demand efficiently. These industries need to partner with experienced CDMOs to manage risks, improve product quality, and reduce time-to-market for new drug launches. Furthermore, the rise of contract-based models has allowed smaller and mid-sized companies to access high-quality manufacturing capabilities without the need for large investments in their own facilities.
CDMO services are crucial for pharmaceutical companies that need to scale production rapidly. With shorter development timelines, companies rely on CDMOs for faster market entry. In addition, the services provided by these organizations are integral to managing intellectual property, enhancing the stability of formulations, and ensuring that products meet the stringent requirements of regulatory authorities like the FDA. These factors are contributing to the substantial growth of the Formulation CDMO Services Market in the US.
Moreover, as the need for outsourcing continues to rise, the Formulation CDMO Services Market is seeing increased competition among CDMOs to offer more advanced technologies, like continuous manufacturing and automated systems. This competitive landscape is further driving innovation in the market, benefiting the pharmaceutical industry at large.
Get an In-Depth Research Analysis of the US Formulation CDMO Services Market Size And Forecast [2025-2032]
Â
Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Sinopep
Frontier Biotechnologies
JYMed
Chengdu Shengnuo Biotechnology
Shanghai Soho-Yiming Pharmaceuticals
Chinese Peptide Company
Ambio Pharmaceuticals
Zhejiang Peptites Biotech
STA Pharmaceutical
Zhejiang Langhua Pharmaceutical
Viva Biotech
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Formulation CDMO Services Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Formulation CDMO Services Market
Solid Formulations
Liquid Formulations
Semi-Solid Formulations
Injectable Formulations
Specialty Formulations
Pharmaceuticals
Biotechnology
Nutraceuticals
Cosmetics and Personal Care
Food and Beverage
Contract Development
Contract Manufacturing
Analytical Services
Stability Testing
Regulatory Services
Small Molecules
Large Molecules
Biologics
Oral Dosage Forms
Topical Dosage Forms
Preclinical
Clinical
Commercial
Scale-Up Services
Custom Manufacturing
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Formulation CDMO Services Market Research Analysis
1. Introduction of the US Formulation CDMO Services Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Formulation CDMO Services Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Formulation CDMO Services Market, By Type
6. US Formulation CDMO Services Market, By Application
7. US Formulation CDMO Services Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Formulation CDMO Services Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/